Abstract |
A series of 4'-[1,2,3] triazole-2'-deoxy-2'-fluoro-β-d-arabinofuranosylcytosines (9-17) were prepared by Cu(I)-mediated [3 + 2] cycloaddition reactions (CuAAC) of 1-(4'-azido-2'-deoxy-2'-fluoro-β-d-arabinofuranosyl)cytosine (1) with appropriate alkynes in good yields. Their structures were fully established by (1)H NMR, (13)C NMR, HRMS, and elemental analysis. Most of these nucleoside analogs exhibited potent anti-HIV-1 activity with no cytotoxicity observed at the highest tested concentration up to 25 μM. Among them, compounds 9, 10 and 13 exhibited extremely potent antiviral activity, thus had a great potential for further development as novel nucleoside reverse transcriptase inhibitors (NRTIs) for the treatment of HIV-1 infection. Besides, the anti-HBV activity of compounds 10, 11 and 17 had been investigated.
|
Authors | Jie Wu, Wenquan Yu, Leixia Fu, Wu He, Yao Wang, Baoshan Chai, Chuanjun Song, Junbiao Chang |
Journal | European journal of medicinal chemistry
(Eur J Med Chem)
Vol. 63
Pg. 739-45
(May 2013)
ISSN: 1768-3254 [Electronic] France |
PMID | 23570720
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier Masson SAS. All rights reserved. |
Chemical References |
- Antiviral Agents
- Hepatitis B Surface Antigens
- Hepatitis B e Antigens
- Triazoles
- Cytidine
|
Topics |
- Antiviral Agents
(chemical synthesis, chemistry, pharmacology)
- Cell Survival
(drug effects)
- Cytidine
(chemical synthesis, chemistry, pharmacology)
- Dose-Response Relationship, Drug
- Drug Design
- Enzyme-Linked Immunosorbent Assay
- HEK293 Cells
- HIV-1
(drug effects)
- Hep G2 Cells
- Hepatitis B Surface Antigens
(metabolism)
- Hepatitis B e Antigens
(metabolism)
- Hepatitis B virus
(drug effects, metabolism)
- Humans
- Models, Chemical
- Molecular Structure
- Triazoles
(chemical synthesis, chemistry, pharmacology)
|